Victor Cohen

5.3k total citations · 3 hit papers
75 papers, 3.4k citations indexed

About

Victor Cohen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Victor Cohen has authored 75 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 13 papers in Surgery. Recurrent topics in Victor Cohen's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Cancer Genomics and Diagnostics (8 papers). Victor Cohen is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Cancer Genomics and Diagnostics (8 papers). Victor Cohen collaborates with scholars based in United States, Canada and South Korea. Victor Cohen's co-authors include Jonathan Passeri, Irene Kuter, Marielle Scherrer‐Crosbie, Heloisa Sawaya, Michael H. Picard, Igal A. Sebag, Bonnie Ky, Robert E. Gerszten, Randolph P. Martin and Elkan F. Halpern and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Victor Cohen

72 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab

2012 573 citations Heloisa Sawaya, Igal A. Sebag et al. profile →
Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients

2011 476 citations Heloisa Sawaya, Igal A. Sebag et al. profile →
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab

2013 398 citations Bonnie Ky, Mary Putt et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victor Cohen United States	26	1.7k	1.1k	718	517	382	75	3.4k
Fredrick S. Whaley United States	18	2.4k 1.4×	1.5k 1.4×	334 0.5×	736 1.4×	423 1.1×	30	4.7k
Tracie L. Miller United States	43	2.7k 1.6×	880 0.8×	290 0.4×	707 1.4×	457 1.2×	150	5.9k
Martina Zaninotto Italy	37	1.6k 0.9×	356 0.3×	588 0.8×	414 0.8×	709 1.9×	255	4.8k
Youjin Je South Korea	31	758 0.4×	1.5k 1.4×	183 0.3×	921 1.8×	187 0.5×	78	4.0k
Suma Konety United States	28	2.9k 1.7×	343 0.3×	478 0.7×	314 0.6×	424 1.1×	77	3.9k
Aldo Clerico Italy	45	4.3k 2.5×	242 0.2×	575 0.8×	852 1.6×	979 2.6×	261	6.9k
Fausto Roila Italy	45	1.0k 0.6×	1.7k 1.6×	315 0.4×	980 1.9×	4.5k 11.7×	135	7.9k
Yong Liu China	30	694 0.4×	185 0.2×	319 0.4×	397 0.8×	581 1.5×	242	3.2k
Arintaya Phrommintikul Thailand	26	1.7k 1.0×	214 0.2×	536 0.7×	277 0.5×	502 1.3×	167	3.8k
Mads Nybo Denmark	37	654 0.4×	311 0.3×	139 0.2×	385 0.7×	542 1.4×	181	4.2k

Countries citing papers authored by Victor Cohen

Since Specialization

Citations

This map shows the geographic impact of Victor Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Cohen more than expected).

Fields of papers citing papers by Victor Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Cohen. The network helps show where Victor Cohen may publish in the future.

Co-authorship network of co-authors of Victor Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Cohen. A scholar is included among the top collaborators of Victor Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Cohen. Victor Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cohen, Victor, et al.. (2024). Sex influence on cancer immunotherapy efficacy and safety in advanced non-small cell lung cancer (NSCLC): A Canadian institution real-world experience.. Journal of Clinical Oncology. 42(16_suppl). e20618–e20618.

Cohen, Victor, et al.. (2024). Sex-Related Differences in Immunotherapy Outcomes of Patients with Advanced Non-Small Cell Lung Cancer. Current Oncology. 31(11). 7379–7389. 2 indexed citations

Dankner, Matthew, Victor Cohen, Lawrence Panasci, et al.. (2024). The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre. Current Oncology. 32(1). 1–1. 3 indexed citations

Ezeife, Doreen A., Eldon Spackman, Rosalyn A. Juergens, et al.. (2022). The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 14. 27 indexed citations

Agulnik, Jason, Andreas I. Papadakis, Carmela Pepe, et al.. (2022). Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC). Current Oncology. 29(2). 1107–1116. 6 indexed citations

Marques, Maud, Lise Tremblay, Nicole Bouchard, et al.. (2019). Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes. Molecular Cancer Therapeutics. 18(9). 1628–1636. 20 indexed citations

Motov, Sergey, Antonios Likourezos, Illya Pushkar, et al.. (2016). Comparison of Intravenous Ketorolac at Three Single-Dose Regimens for Treating Acute Pain in the Emergency Department: A Randomized Controlled Trial. Annals of Emergency Medicine. 70(2). 177–184. 76 indexed citations

Hoffer, L. John, Line Robitaille, Robert Zakarian, et al.. (2015). High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial. PLoS ONE. 10(4). e0120228–e0120228. 88 indexed citations

Fromm, Christian, et al.. (2015). Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department. Journal of Emergency Medicine. 49(2). 175–182. 58 indexed citations

10.

Kasymjanova, Goulnar, Chantal Robitaille, Victor Cohen, et al.. (2014). Comparison of the Yield of Different Diagnostic Procedures for Cellular Differentiation and Genetic Profiling of Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(8). 1120–1125. 7 indexed citations

11.

Esfahani, Khashayar, Jason Agulnik, & Victor Cohen. (2014). A Systemic Review of Resistance Mechanisms and Ongoing Clinical Trials in ALK-Rearranged Non-Small Cell Lung Cancer. Frontiers in Oncology. 4. 174–174. 18 indexed citations

12.

Ky, Bonnie, Mary Putt, Heloisa Sawaya, et al.. (2013). Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab. Journal of the American College of Cardiology. 63(8). 809–816. 398 indexed citations breakdown →

13.

Cohen, Victor, et al.. (2009). Tarka® (Trandolapril/Verapamil Hydrochloride Extended-Release) overdose. Journal of Emergency Medicine. 40(3). 291–295. 12 indexed citations

14.

Cohen, Victor, et al.. (2009). Cardiac Arrest With Residual Blindness After Overdose of Tessalon® (Benzonatate) Perles. Journal of Emergency Medicine. 41(2). 166–171. 13 indexed citations

15.

Tagalakis, Vicky, et al.. (2007). High Risk of Deep Vein Thrombosis in Patients with Non-small Cell Lung Cancer: A Cohort Study of 493 Patients. Journal of Thoracic Oncology. 2(8). 729–734. 90 indexed citations

16.

Cohen, Victor, Jason Agulnik, Jonathan Jarry, et al.. (2006). Evaluation of denaturing high‐performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall‐cell lung cancer. Cancer. 107(12). 2858–2865. 51 indexed citations

17.

Cohen, Victor & Fadlo R. Khuri. (2005). Chemoprevention of lung cancer: concepts and strategies. Expert Review of Anticancer Therapy. 5(3). 549–565. 4 indexed citations

18.

Cohen, Victor & Fadlo R. Khuri. (2004). Chemoprevention of lung cancer. Current Opinion in Pulmonary Medicine. 10(4). 279–283. 27 indexed citations

19.

Cohen, Victor, et al.. (2001). Effects of cocaine on the coronary arteries. American Heart Journal. 142(3). 402–410. 93 indexed citations

20.

Netscher, David T., et al.. (1998). Temporal changes in grip and pinch strength after open carpal tunnel release and the effect of ligament reconstruction. The Journal Of Hand Surgery. 23(1). 48–54. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact